Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography

详细信息    查看全文

• 作者：R. Todd Stravitz¹ ;   ; ^{rstravit@vcu.edu} ; Ton Lisman³ ; Velimir A. Luketic¹ ; Richard K. Sterling¹ ; Puneet Puri¹ ; Michael Fuchs¹ ; Ashraf Ibrahim² ; William M. Lee⁴ ; Arun J. Sanyal¹
• 关键词：Acute liver failure ; Coagulopathy ; Hepatic encephalopathy ; Hemostasis ; Thromboelastography
• 刊名：Journal of Hepatology
• 出版年：2012
• 出版时间：January 2012
• 年：2012
• 卷：56
• 期：1
• 页码：129-136
• 全文大小：659 K

文摘

sion=""1.0"" encoding=""UTF-8""?>

Background & Aims

Patients with acute liver injury/failure (ALI/ALF) are assumed to have a bleeding diathesis on the basis of elevated INR; however, clinically significant bleeding is rare. We hypothesized that patients with ALI/ALF have normal hemostasis despite elevated INR.

Methods

Fifty-one patients with ALI/ALF were studied prospectively using thromboelastography (TEG), which measures the dynamics and physical properties of clot formation in whole blood. ALI was defined as an INR ?.5 in a patient with no previous liver disease, and ALF as ALI with hepatic encephalopathy.

Results

Thirty-seven of 51 patients (73 % ) had ALF and 22 patients (43 % ) underwent liver transplantation or died. Despite a mean INR of 3.4 ¡À 1.7 (range 1.5?.6), mean TEG parameters were normal, and 5 individual TEG parameters were normal in 32 (63 % ). Low maximum amplitude, the measure of ultimate clot strength, was confined to patients with platelet counts <126 ¡Á 10⁹/L. Maximum amplitude was higher in patients with ALF than ALI and correlated directly with venous ammonia concentrations and with increasing severity of liver injury assessed by elements of the systemic inflammatory response syndrome. All patients had markedly decreased procoagulant factor V and VII levels, which were proportional to decreases in anticoagulant proteins and inversely proportional to elevated factor VIII levels.

Conclusions

Despite elevated INR, most patients with ALI/ALF maintain normal hemostasis by TEG, the mechanisms of which include an increase in clot strength with increasing severity of liver injury, increased factor VIII levels, and a commensurate decline in pro- and anticoagulant proteins.